TIMP‐2 as a Potential Indicator of Persistent Arthralgia in Chikungunya: Evidence From a Brazilian Cohort Study
Journal of Medical Virology · 2025-10 · 97 (10)
DOI: 10.1002/jmv.70635 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Medical Virology, online erschienen am 14.10.2025. Verfasst von Ana Clara Santos Costa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunomodulation and New Therapeutic Approaches, Center for Research in Therapeutic Innovation - Suely Galdino (NUPIT-SG), Center for B…. Hauptthemen laut MEDLINE: Arthralgia, Chikungunya Fever, Tissue Inhibitor of Metalloproteinase-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES); the National Council for Scientific and Technological D….
Abstract (Originalsprache)
Chikungunya virus (CHIKV) infection can trigger a sustained inflammatory response, often leading to chronic musculoskeletal pain. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) may contribute to the persistence of arthralgia through their involvement in joint tissue remodeling and degradation. This study aimed to evaluate the potential of MMPs and TIMPs as plasma biomarkers of persistent arthralgia in individuals diagnosed with Chikungunya Fever (CHIKF). A prospective cohort study was conducted using plasma samples from 133 CHIKF‐positive individuals recruited during the acute or post‐acute phases. Sociodemographic and clinical data were collected at outpatient visits. At 90 days post‐symptom onset, participants were assessed for persistent arthralgia using a self‐reported Visual Analog Scale (VAS) for joint pain and categorized into two groups: Recovered (VAS 0–3, n = 71) or Persistent Arthralgia (VAS 4–10, n = 62). Plasma levels of MMP‐2, MMP‐9, and TIMP‐2 were quantified using multiplex bead‐based ELISA (LegendPlex), while MMP‐1, MMP‐3, MMP‐14/MT1‐MMP, and TIMP‐1 were measured via sandwich ELISA. Plasma samples from 51 CHIKV‐negative individuals were used as controls. Statistical analyzes were performed using GraphPad Prism v9.0, IBM SPSS Statistics and Stata. Among post‐acute participants, lower MMP‐2 levels were significantly associated with recovery compared to those with persistent arthralgia and to controls. TIMP‐2 levels varied significantly across clinical outcomes, supporting its involvement in CHIKV‐induced pathology. Multivariate analysis identified swollen joints, skin rash, and elevated TIMP‐2 levels during the post‐acute phase as independent predictors of persistent arthralgia in the chronic phase. No significant differences were observed for MMP‐1, MMP‐3, MMP‐9, MMP‐14, or TIMP‐1. These findings suggest a potential role for TIMP‐2 and musculoskeletal manifestations as early indicators of chronic joint symptoms following CHIKV infection. Further studies are needed to validate these biomarkers and better understand the mechanisms underlying chronic Chikungunya‐related arthralgia across diverse populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunomodulation and New Therapeutic Approaches, Center for Research in Therapeutic Innovation - Suely Galdino (NUPIT-SG), Center for Biosciences - CB, Federal University of Pernambuco, Recife, Pernambuco,…
- Department of Nursing, Nova Esperança School of Nursing (FACENE), João Pessoa, Paraíba, Brazil.
- Head of the Rheumatology Service of HC, Rheumatology Service of the Federal University of Pernambuco/Center for Health Sciences, Recife, Pernambuco, Brazil.
- Evandro Chagas National Institute of Infectious Diseases - Fiocruz, Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Rio de Janeiro, Brazil.
- Campus Professor Cinobelina Elvas, Federal University of Piauí (UFPI), Bom Jesus, Piauí, Brazil.
ORCID-Profile: Ana Clara Santos Costa, Anderson Felix Dos Santos, Gabriela Cavalcanti Lima Albuquerque, Michelle Melgarejo da Rosa, Jamile Taniele-Silva, Angela Luzia Branco Pinto Duarte, Maira Galdino da Rocha Pitta, André Machado de Siqueira, Amanda Pinheiro de Barros Albuquerque, Moacyr Jesus Barreto de Melo Rego
Förderung
- This study was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES); the National Council for Scientific and Technological D…
Zitieren
APA
Costa, A. C. S., Santos, A. F. D., Albuquerque, G. C. L., da Rosa, M. M., Taniele-Silva, J., Duarte, A. L. B. P., da Rocha Pitta, M. G., de Siqueira, A. M., de Barros Albuquerque, A. P., & de Melo Rego, M. J. B. (2025). TIMP‐2 as a Potential Indicator of Persistent Arthralgia in Chikungunya: Evidence From a Brazilian Cohort Study. Journal of Medical Virology, 97(10). https://doi.org/10.1002/jmv.70635
Vancouver
Costa ACS, Santos AFD, Albuquerque GCL, da Rosa MM, Taniele-Silva J, Duarte ALBP, et al. TIMP‐2 as a Potential Indicator of Persistent Arthralgia in Chikungunya: Evidence From a Brazilian Cohort Study. Journal of Medical Virology. 2025;97(10). doi:10.1002/jmv.70635
BibTeX
@article{Costa2025,
author = {Costa, Ana Clara Santos and Santos, Anderson Felix Dos and Albuquerque, Gabriela Cavalcanti Lima and da Rosa, Michelle Melgarejo and Taniele-Silva, Jamile and Duarte, Angela Luzia Branco Pinto and da Rocha Pitta, Maira Galdino and de Siqueira, André Machado and de Barros Albuquerque, Amanda Pinheiro and de Melo Rego, Moacyr Jesus Barreto},
title = {TIMP‐2 as a Potential Indicator of Persistent Arthralgia in Chikungunya: Evidence From a Brazilian Cohort Study},
journal = {Journal of Medical Virology},
year = {2025},
volume = {97},
number = {10},
doi = {10.1002/jmv.70635}
}
EUVIMED